Molecular Partners Ag MOLN
NASDAQ MOLN
$4.38 +0.15 (+3.68%)
As of: Aug 21, 2026 · 10:12 AM EDT

Molecular Partners Ag (MOLN) Shares Outstanding (2020 - 2026)

Molecular Partners Ag (MOLN) posted quarterly Shares Outstanding (Entity) of $40.4 million for Q4 2025, little changed year-over-year from $40.4 million in Q4 2024, and little changed quarter-over-quarter from $40.4 million in Q2 2025.

Molecular Partners Ag (MOLN) Shares Outstanding (2020 - 2026) Analysis & Trends

Molecular Partners Ag (MOLN) has reported Shares Outstanding (Entity) for 6 consecutive years, with $40.4 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Shares Outstanding (Entity) changed 0.03% year-over-year to $40.4 million; the TTM figure through Dec 2025 stood at $40.4 million (changed 0.03% YoY), while the FY2025 annual figure was $40.4 million, changed 0.03% from the prior year.
  • Shares Outstanding (Entity) was little changed at $40.4 million in Q4 2025 per MOLN's latest filing, from $40.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Entity) topped out at $40.4 million in Q2 2025 and bottomed at $29.7 million in Q2 2021.
  • Historically, Shares Outstanding (Entity) has averaged $36.1 million across 5 years, with a median of $36.3 million in 2023.
  • Annual changes were most pronounced in 2023 — Shares Outstanding (Entity) grew 11.78% — and 2025, when it advanced 0.03%.
  • Molecular Partners Ag's Shares Outstanding (Entity) stood at $32.3 million in 2021, then climbed by 11.62% to $36.0 million in 2022, then advanced by 0.86% to $36.4 million in 2023, then rose by 11.03% to $40.4 million in 2024, then climbed by 0.03% to $40.4 million in 2025.
  • Business Quant data shows MOLN's Shares Outstanding (Entity) at $40.4 million in Q4 2025, $40.4 million in Q2 2025, and $40.4 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Vertex Pharmaceuticals 139.76 Bn 131.91 Bn 2.84 Bn 253.70 Mn
2 Regeneron Pharmaceuticals 86.51 Bn 78.51 Bn 3.93 Bn 102.80 Mn
3 Argenx Se 65.74 Bn 60.56 Bn 1.37 Bn 62.19 Mn
4 Moderna 59.39 Bn 54.26 Bn 52.00 Mn 398.00 Mn
5 BeOne Medicines 42.24 Bn 37.15 Bn 1.53 Bn 111.58 Mn
6 Alnylam Pharmaceuticals 31.78 Bn 28.47 Bn 992.69 Mn 133.61 Mn
7 BioNTech SE 28.65 Bn 10.26 Bn 668.28 Mn 241.70 Mn
8 Insmed 27.58 Bn 26.42 Bn 358.27 Mn 217.35 Mn
9 Royalty Pharma 27.22 Bn 26.39 Bn - 445.06 Mn
10 Molecular Partners Ag 163.25 Mn 163.25 Mn - 37.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 37.27 Mn
Dec 31, 2025 37.27 Mn
Sep 30, 2025 37.39 Mn
Jun 30, 2025 37.39 Mn
Mar 31, 2025 34.03 Mn
Dec 31, 2024 34.03 Mn
Sep 30, 2024 33.18 Mn
Jun 30, 2024 33.18 Mn
Mar 31, 2024 32.77 Mn
Dec 31, 2023 32.77 Mn
Sep 30, 2023 32.83 Mn
Jun 30, 2023 32.83 Mn
Mar 31, 2023 32.47 Mn
Dec 31, 2022 32.47 Mn
Sep 30, 2022 32.50 Mn
Jun 30, 2022 32.50 Mn
Mar 31, 2022 31.01 Mn
Dec 31, 2021 31.01 Mn
Sep 30, 2021 29.71 Mn
Jun 30, 2021 29.71 Mn